FeaturesSignalPricingFounders
MG

Merck Global Health Innovation Fund

Corporate VCActive

Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare

Whitehouse Station, United StatesFounded 2010merckghifund.com/
63
Investments
16
Exits
—
AUM
25.4%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Merck Global Health Innovation Fund.

Get started free

Investment Thesis & Strategy

Merck GHI invests in various stages of fintech and healthcare companies, leveraging its expertise in the healthcare sector to support innovative ventures. They seek companies that align with Merck's global healthcare focus.

Investment Activity

Deals per year over the last 6 years

1
2017
3
2018
1
2019
0
2020
6
2021
1
2022

Portfolio Companies

Selected investments from their portfolio of 63 companies

C
Cellino
Biotech · Series A, 2022
Active
N
Notable
Healthcare · Series B, 2021
Active
B
Big Health
Healthcare · Series B, 2021
Active
V
Veda
Healthcare · Series B, 2021
Active
S
Sana
Healthcare · Series B, 2021
Active
L
LetsGetChecked
Healthcare · Series B, 2021
Active
B
BioAge Labs
Biotech · Series B, 2021
Active
P
PathAI
AI/ML · Series C+, 2019
Active
P
Pear Therapeutics
Healthcare · Growth, 2018
Active
K
Karius
Healthcare · Series B, 2018
Active
S
Science 37
Healthcare · Series B, 2018
Active
T
Tempus
Healthcare · Series C+, 2017
Active

Frequently Asked Questions

Merck Global Health Innovation Fund focuses on Series A, Series B stage investments.

Related Investors

Brand Capital

Mumbai, India · 570 deals

Salesforce Ventures

San Francisco, United States · 463 deals

Qualcomm Ventures

San Diego, United States · 374 deals

SoftBank Capital

Tokyo, Japan · 279 deals

Samsung Ventures

Seoul, South Korea · 231 deals

Dell Technologies Capital

Palo Alto, United States · 189 deals